Virtu KCG Holdings’s Filana Therapeutics FLNA Stock Holding History

Virtu KCG Holdings’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$46K	Buy	11,130 +9,173	+469%	+$43.3K	﹤0.01%	2608
2017 Q1	$12K	Buy	+1,957	New	+$8.88K	﹤0.01%	3016
2016 Q4	–	Sell	-22,295	Closed	-$156K	–	3749
2016 Q3	$156K	Buy	22,295 +20,116	+923%	+$333K	﹤0.01%	2483
2016 Q2	$33K	Buy	+2,179	New	+$34.6K	﹤0.01%	2739
2016 Q1	–	Sell	-5,158	Closed	-$63K	–	3539
2015 Q4	$63K	Buy	5,158 +92	+2%	+$1.22K	﹤0.01%	3115
2015 Q3	$65K	Buy	5,066 +827	+20%	+$10.4K	﹤0.01%	2944
2015 Q2	$51K	Buy	+4,239	New	+$58.1K	﹤0.01%	3058
2015 Q1	–	Sell	-7,482	Closed	-$106K	–	3773
2014 Q4	$106K	Buy	+7,482	New	+$130K	﹤0.01%	3202
2014 Q3	–	Sell	-5,121	Closed	-$206K	–	3995
2014 Q2	$206K	Buy	+5,121	New	+$190K	﹤0.01%	3041

Other funds holding FLNA

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu KCG Holdings's FLNA Position: Q2 2017 in Review

Virtu KCG Holdings increased its Filana Therapeutics (FLNA) stake by 469% in Q2 2017, buying an estimated $43.3K and bringing the position to 11,130 shares worth $46K. The position accounts for ﹤0.01% of the portfolio, ranked #2608.

Virtu KCG Holdings first reported a position in FLNA in Q2 2014 and has held it in 9 quarters since. The position peaked at $206K in Q2 2014. 33 funds tracked by Wall St. Rank hold FLNA as of Q2 2017.

Virtu KCG Holdings held 11,130 shares of Filana Therapeutics worth $46K as of Q2 2017.
Virtu KCG Holdings bought 9,173 Filana Therapeutics shares in Q2 2017, an estimated $43.3K.
Filana Therapeutics made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2608 holding.
Virtu KCG Holdings first reported a position in Filana Therapeutics in Q2 2014 and has held it in 9 quarters since.
Virtu KCG Holdings's Filana Therapeutics position peaked at $206K in Q2 2014.
33 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.